MIM
Monashee Investment Management Portfolio holdings
AUM
$190M
This Quarter Return
+12.57%
1 Year Return
+42.84%
3 Year Return
+185.9%
5 Year Return
+237.5%
10 Year Return
+2,730.86%
AUM
$419M
AUM Growth
+$419M
(+16%)
Cap. Flow
+$118M
Cap. Flow
% of AUM
28.12%
Top 10 Holdings %
Top 10 Hldgs %
66.93%
Holding
99
New
53
Increased
2
Reduced
10
Closed
24
Top Buys
| 1 |
Structure Therapeutics
GPCR
|
$19.9M |
| 2 |
Invesco QQQ Trust
QQQ
|
$10.3M |
| 3 |
RadNet
RDNT
|
$9.79M |
| 4 |
Nextracker
NXT
|
$7.97M |
| 5 |
Casella Waste Systems
CWST
|
$7.69M |
Top Sells
| 1 |
iShares Russell 2000 ETF
IWM
|
$16.9M |
| 2 |
Alight
ALIT
|
$7.24M |
| 3 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$5.18M |
| 4 |
Viking Therapeutics
VKTX
|
$5M |
| 5 |
Biohaven
BHVN
|
$4.78M |
Sector Composition
| 1 | Healthcare | 20.13% |
| 2 | Technology | 3.56% |
| 3 | Industrials | 3.21% |
| 4 | Consumer Discretionary | 2.86% |
| 5 | Real Estate | 1.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SLGC
26
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $1.85M | 0.44% |
799,784
-190,077
| -19% | -$439K |
|
27
AN2 Therapeutics
ANTX
$35.3M
| $1.55M | 0.37% |
181,995
-65,472
| -26% | -$557K |
|
|
28
Alight
ALIT
$2.07B
| $1.54M | 0.37% |
166,288
-783,712
| -82% | -$7.24M |
|
29
Skyward Specialty Insurance
SKWD
$1.98B
| $1.52M | 0.36% |
+59,861
| New | +$1.52M |
|
30
Blue Bird Corp
BLBD
$1.83B
| $1.46M | 0.35% |
+65,000
| New | +$1.46M |
|
31
OneSpaWorld
OSW
$2.3B
| $1.45M | 0.35% |
+120,000
| New | +$1.45M |
|
32
Vivid Seats
SEAT
$100M
| $1.38M | 0.33% |
+174,100
| New | +$1.38M |
|
33
Guardant Health
GH
$8.11B
| $1.32M | 0.32% |
+37,000
| New | +$1.32M |
|
34
Atlas Energy Solutions
AESI
$1.35B
| $1.3M | 0.31% |
75,000
-125,000
| -63% | -$2.17M |
|
|
KLRS
35
Kalaris Therapeutics, Inc. Common Stock
KLRS
$85.5M
| $1.28M | 0.3% |
+375,000
| New | +$1.28M |
|
36
Kura Oncology
KURA
$732M
| $1.27M | 0.3% |
+120,000
| New | +$1.27M |
|
|
37
Biohaven
BHVN
$1.71B
| $1.2M | 0.29% |
50,000
-200,000
| -80% | -$4.78M |
|
38
NewAmsterdam Pharma
NAMS
$2.8B
| $1.13M | 0.27% |
+95,000
| New | +$1.13M |
|
39
X4 Pharmaceuticals
XFOR
$70M
| $1.11M | 0.27% |
+572,784
| New | +$1.11M |
|
|
STER
40
DELISTED
Sterling Check Corp. Common Stock
STER
| $1.1M | 0.26% |
+89,529
| New | +$1.1M |
|
41
TScan Therapeutics
TCRX
$106M
| $1M | 0.24% |
+400,000
| New | +$1M |
|
42
Enlight Renewable Energy
ENLT
$3.35B
| $892K | 0.21% |
50,263
-43,920
| -47% | -$780K |
|
43
Black Diamond Therapeutics
BDTX
$164M
| $859K | 0.2% |
+170,000
| New | +$859K |
|
44
World Kinect Corp
WKC
$1.52B
| $827K | 0.2% |
+40,000
| New | +$827K |
|
45
Kodiak Gas Services
KGS
$3.1B
| $624K | 0.15% |
+38,400
| New | +$624K |
|
46
Savers
SVV
$1.88B
| $593K | 0.14% |
+25,000
| New | +$593K |
|
47
Cogent Biosciences
COGT
$1.83B
| $592K | 0.14% |
+50,000
| New | +$592K |
|
48
Cidara Therapeutics
CDTX
$1.61B
| $417K | 0.1% |
369,099
| – | – |
|
49
Madison Square Garden
MSGE
$1.92B
| $336K | 0.08% |
+10,000
| New | +$336K |
|
50
CAVA Group
CAVA
$7.64B
| $205K | 0.05% |
+5,000
| New | +$205K |
|